Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
Stocks in this Quantisnow insightHealth Care
Historical context for TECH
Across the 11 sessions after earlier TECH headlines, the stock closed higher 4 times and lower 7 times, with a median move of 1.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TECH | SPY |
|---|---|---|---|
| Jan 20, 2026 | Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results | +1.3% | -2.0% |
| Dec 23, 2025 | Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference | +0.5% | +0.5% |
| Dec 11, 2025 | Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology | -0.9% | +0.2% |
| Dec 9, 2025 | Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis | -2.4% | -0.1% |
| Nov 25, 2025 | Bio-Techne to Present at Upcoming Investor Conferences | +3.7% | +0.9% |
| Nov 18, 2025 | Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio | -0.8% | -0.8% |
Keep researching TECH
- TECH insider tradesEvery buy and sale reported by Bio-Techne Corp officers, directors and large holders.
- TECH earnings historyPast Bio-Techne Corp earnings releases, newest first.
- TECH financial statementsRevenue, profit, cash flow and balance sheet from Bio-Techne Corp's SEC filings.
- TECH dividend historyDividends Bio-Techne Corp has declared, with ex-dates and payment dates.
Quantisnow market dataNASDAQ
TECH
Bio-Techne Corp
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for TECH
Full TECH profile on Quantisnow Follow TECH and get a push notification the moment its next story breaks.